AGILON HEALTH INC (AGL) Stock Earnings Estimates
USA - New York Stock Exchange - NYSE:AGL - US00857U1079 - Common Stock
0.7981 USD
-0.06 (-6.55%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.708B 47.70% | 4.316B 59.38% | 6.061B 40.41% | 5.882B -2.95% | 6.023B 2.40% | 6.643B 10.29% | 7.531B 13.37% | 8.747B 16.15% | 9.839B 12.48% | 7.989B -18.80% | |
| EBITDA YoY % growth | -106.63M 71.89% | -211.972M -98.79% | -264.071M -24.58% | -267.772M -1.40% | -106.446M 60.25% | -37.614M 64.66% | 35.467M 194.29% | 126.25M 255.96% | 203.72M 61.36% | 288.46M 41.60% | |
| EBIT YoY % growth | -120.4M 69.44% | -232.133M -92.80% | -288.534M -24.30% | -374.992M -29.96% | -198.938M 46.95% | -118.203M 40.58% | -39.087M 66.93% | 27.674M 170.80% | 102.72M 271.18% | 183.92M 79.05% | |
| Operating Margin | -4.45% | -5.38% | -4.76% | -6.38% | -3.30% | -1.78% | -0.52% | 0.32% | 1.04% | 2.30% | |
| EPS YoY % growth | -0.26 75.70% | -0.49 -88.46% | -0.63 -28.57% | -0.79 -25.81% | -0.42 46.40% | -0.27 36.71% | -0.15 45.53% | N/A | N/A | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.27 -4.36% | -0.03 -200.66% | -0.12 52.17% | -0.11 58.27% | -0.16 42.14% | 0.00 100.00% | -0.07 40.88% | -0.11 1.40% | -0.23 -47.97% |
| Revenue Q2Q % growth | 1.476B -3.05% | 1.602B 4.52% | 1.479B 6.02% | 1.491B 3.88% | 1.539B 4.27% | 1.768B 10.36% | 1.582B 6.96% | 1.592B 6.77% | 1.626B 5.65% |
| EBITDA Q2Q % growth | -105.099M -30.72% | 15.761M 203.46% | -23.739M 76.69% | -31.625M 71.16% | -56.673M 46.08% | 24.745M 57.00% | -6.767M 71.49% | -19.796M 37.40% | -72.922M -28.67% |
| EBIT Q2Q % growth | -112.803M -8.05% | -16.051M 27.41% | -46.24M 60.15% | -53.348M 59.36% | -78.954M 30.01% | 707K 104.40% | -31.108M 32.72% | -51.611M 3.26% | -98.071M -24.21% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.27 6.90% | -0.16 | -0.11 | -68.86% |
| Q2 2025 Q2Q % growth | -0.25 -257.14% | -0.12 | -0.13 | -114.66% |
| Q1 2025 Q2Q % growth | 0.03 400.00% | -0.01 | 0.04 | 422.51% |
| Q4 2024 Q2Q % growth | -0.26 36.59% | -0.23 | -0.03 | -12.63% |
| Q3 2024 Q2Q % growth | -0.29 -262.50% | -0.11 | -0.18 | -171.08% |
| Q2 2024 Q2Q % growth | -0.07 -75.00% | -0.08 | 0.01 | 14.11% |
| Q1 2024 Q2Q % growth | -0.01 -125.00% | -0.01 | 0.00 | 18.64% |
| Q4 2023 Q2Q % growth | -0.41 -192.86% | -0.30 | -0.11 | -34.90% |
| Q3 2023 Q2Q % growth | -0.08 -14.29% | -0.06 | -0.02 | -39.16% |
| Q2 2023 Q2Q % growth | -0.04 20.00% | -0.03 | -0.01 | -55.98% |
| Q1 2023 Q2Q % growth | 0.04 | 0.02 | 0.02 | 81.50% |
| Q4 2022 Q2Q % growth | -0.14 | -0.09 | -0.05 | -61.18% |
| Q3 2022 Q2Q % growth | -0.07 22.22% | -0.05 | -0.02 | -38.61% |
| Q2 2022 Q2Q % growth | -0.05 93.67% | -0.02 | -0.03 | -175.03% |
| Q1 2022 Q2Q % growth | 0.00 100.00% | 0.00 | 0.00 | -100.00% |
| Q4 2021 Q2Q % growth | -0.14 | -0.11 | -0.03 | -26.01% |
| Q3 2021 Q2Q % growth | -0.09 | -0.10 | 0.01 | 7.82% |
| Q2 2021 Q2Q % growth | -0.79 | -0.06 | -0.73 | -1,322.14% |
| Q1 2021 Q2Q % growth | -0.05 | -0.03 | -0.02 | -65.02% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.435B -1.08% | 1.438B | -2.679M | -0.19% |
| Q2 2025 Q2Q % growth | 1.395B -5.92% | 1.486B | -91.018M | -6.13% |
| Q1 2025 Q2Q % growth | 1.533B -4.46% | 1.519B | 13.782M | 0.91% |
| Q4 2024 Q2Q % growth | 1.522B 44.16% | 1.531B | -8.514M | -0.56% |
| Q3 2024 Q2Q % growth | 1.451B 19.35% | 1.485B | -34.068M | -2.29% |
| Q2 2024 Q2Q % growth | 1.483B 29.04% | 1.575B | -92.242M | -5.86% |
| Q1 2024 Q2Q % growth | 1.604B 41.21% | 1.62B | -15.646M | -0.97% |
| Q4 2023 Q2Q % growth | 1.056B 53.10% | 1.028B | 28.073M | 2.73% |
| Q3 2023 Q2Q % growth | 1.216B 74.94% | 1.149B | 66.66M | 5.80% |
| Q2 2023 Q2Q % growth | 1.149B 71.47% | 1.122B | 27.052M | 2.41% |
| Q1 2023 Q2Q % growth | 1.136B 73.88% | 1.089B | 47.147M | 4.33% |
| Q4 2022 Q2Q % growth | 689.8M 49.02% | 671M | 18.8M | 2.80% |
| Q3 2022 Q2Q % growth | 694.9M 51.53% | 660.61M | 34.29M | 5.19% |
| Q2 2022 Q2Q % growth | 670.1M 34.29% | 654.46M | 15.64M | 2.39% |
| Q1 2022 Q2Q % growth | 653.4M 58.17% | 648.65M | 4.75M | 0.73% |
| Q4 2021 Q2Q % growth | 462.9M | 457.42M | 5.48M | 1.20% |
| Q3 2021 Q2Q % growth | 458.6M 46.66% | 454.85M | 3.75M | 0.82% |
| Q2 2021 Q2Q % growth | 499M 69.96% | 478.03M | 20.97M | 4.39% |
| Q1 2021 Q2Q % growth | 413.1M 41.96% | 409.55M | 3.55M | 0.87% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.95% | -37.47% | 0.21% | -28.74% |
| Revenue | 0% | 0.2% | 0.02% | 0.15% |